ES2071833T3 - Agente para neutralizar la actividad procoagulante asociada a celulas tumorales. - Google Patents

Agente para neutralizar la actividad procoagulante asociada a celulas tumorales.

Info

Publication number
ES2071833T3
ES2071833T3 ES90916090T ES90916090T ES2071833T3 ES 2071833 T3 ES2071833 T3 ES 2071833T3 ES 90916090 T ES90916090 T ES 90916090T ES 90916090 T ES90916090 T ES 90916090T ES 2071833 T3 ES2071833 T3 ES 2071833T3
Authority
ES
Spain
Prior art keywords
agent
neutralize
tumor cells
activity associated
procoagulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90916090T
Other languages
English (en)
Inventor
Christiaan Reutelingsperger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2071833T3 publication Critical patent/ES2071833T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

EL OBJETO DE ESTA INVENCION ES EL USO DE UNA PROTEINA ANTICOAGULANTE DE LA FAMILIA ANEXINA COMO AGENTE PARA PREVENIR LA METASTASIS DE TUMORES.
ES90916090T 1989-11-11 1990-11-08 Agente para neutralizar la actividad procoagulante asociada a celulas tumorales. Expired - Lifetime ES2071833T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3937607A DE3937607A1 (de) 1989-11-11 1989-11-11 Verwendung eines antikoagulanz zur behandlung von tumorerkrankungen

Publications (1)

Publication Number Publication Date
ES2071833T3 true ES2071833T3 (es) 1995-07-01

Family

ID=6393365

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90916090T Expired - Lifetime ES2071833T3 (es) 1989-11-11 1990-11-08 Agente para neutralizar la actividad procoagulante asociada a celulas tumorales.

Country Status (9)

Country Link
EP (1) EP0500602B1 (es)
JP (1) JPH05501876A (es)
AT (1) ATE120371T1 (es)
CA (1) CA2068312A1 (es)
DE (2) DE3937607A1 (es)
DK (1) DK0500602T3 (es)
ES (1) ES2071833T3 (es)
HU (1) HU208636B (es)
WO (1) WO1991007187A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0743861B1 (en) * 1994-01-24 2003-04-16 Neorx Corporation Radiolabeled annexins
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
EP0765166B1 (en) * 1994-06-16 2003-05-21 Neorx Corporation Radiolabeled annexin-galactose conjugates
CA2206274C (en) * 1994-12-07 2009-06-30 Neorx Corporation Radiolabeled annexin-galactose cluster conjugates
EP1486509A3 (en) * 1994-12-07 2005-03-23 Neorx Corporation Radiolabeled annexin-galactose cluster conjugates
US5696092A (en) * 1995-03-07 1997-12-09 George Washington University Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers
US5935860A (en) 1995-03-07 1999-08-10 The George Washington University Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia
US6288039B1 (en) 1995-03-07 2001-09-11 George Washington University Pharmaceutical compositions methods and kits for treatment and diagnosis of breast cancer
US6509316B2 (en) 1995-03-07 2003-01-21 George Washington University Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer
EP1520588B1 (en) 1998-07-13 2014-12-24 Board Of Regents, The University Of Texas System Uses of antibodies to aminophospholipids for cancer treatment
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
IL140701A0 (en) 1998-07-13 2002-02-10 Univ Texas Cancer treatment methods using antibodies to aminophospholipids
JP2002520297A (ja) 1998-07-13 2002-07-09 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム アミノリン脂質に結合する治療結合体を用いる癌処置方法
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
EP1839670A3 (en) 2001-02-21 2009-11-11 Alavita Pharmaceuticals, Inc. Modified Annexin Proteins and their use against thrombosis
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem

Also Published As

Publication number Publication date
JPH05501876A (ja) 1993-04-08
DE3937607A1 (de) 1991-05-16
WO1991007187A1 (de) 1991-05-30
HU9201552D0 (en) 1992-08-28
EP0500602A1 (de) 1992-09-02
DK0500602T3 (da) 1995-07-10
EP0500602B1 (de) 1995-03-29
ATE120371T1 (de) 1995-04-15
CA2068312A1 (en) 1991-05-12
HU208636B (en) 1993-12-28
DE59008813D1 (de) 1995-05-04
HUT61202A (en) 1992-12-28

Similar Documents

Publication Publication Date Title
ES2071833T3 (es) Agente para neutralizar la actividad procoagulante asociada a celulas tumorales.
AR227063A1 (es) Procedimiento para la produccion de nuevos acidos 7-amino-1-ciclopropil-4-oxo-1,4-dihidro-(1,6-y 1,8-naftiridina o quinolina)-3-carboxilicos
DE3677062D1 (de) Quelle geladener teilchen.
IT8025713A0 (it) Analoghi di 7-ossabicicloeptano e 7-ossabicicloeptene prostaglandina.
DE69000210D1 (de) Herstellung von olefinen.
ES516556A0 (es) Procedimiento para la obtencion de acidos 1-carboxi-(azaalcanoil o azaaralcanoil)-indolin-2-carboxilicos.
ES517408A0 (es) Procedimiento para la preparacion de biocatalizadores de actividad enzimatica.
NO862353L (no) Human tumornekrosefaktor.
IT8119297A0 (it) Procedimento di iniezione e diformazione della miscela, come pure dispositivo per la realizzazione dello stesso.
MX26901A (es) Procedimiento para la reduccion directa de material.
FI850438L (fi) Foerfarande och anordning foer detaktering av biologiskt aktiva aemnen.
SE8500845L (sv) Forfarande for framstellning av glyoxylylspermidin och anvendningen derav for framstellning av 15-deoxispergualin-beslektade foreningar
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
ES2051721T3 (es) Productos activos para impedir las metastasis tumorales.
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
DE3481167D1 (de) Sebosuppressive kosmetische mittel, enthaltend alkoxyaryl-alkanole.
IT8319545A0 (it) Impiego di colecalciferol-derivati.
IT7926292A0 (it) Preparazione di alfa beta-dialdeidi e di alfa beta-diacidi insaturi o saturi.
DE68910347D1 (de) Herstellung von elektrischen Stiften.
IT8321128A0 (it) Impiego di uncolecalciferolderivato.
IT8323139A0 (it) Caviglia per l'assemblaggio di parti di mobili.
IT8621227V0 (it) Ceppo frenante con molla.
SU790670A1 (ru) Хлорид 2-фенил-4-(3,4-диметоксифенил)-7,8-бензо-5,6-дигидротиахромилия, обладающий днк-тропным и ингибирующим биосинтез рнк действием
SU681809A1 (ru) 7-Замещенные 6-азалумазины, обладающие противовоспалительной активностью
IT7868329A0 (it) Procedimento perfezionato per la fabbricazione di mobili

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 500602

Country of ref document: ES